386 related articles for article (PubMed ID: 29264970)
1. Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects.
Hafner LM; Timms P
Expert Rev Vaccines; 2018 Jan; 17(1):57-69. PubMed ID: 29264970
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia trachomatis: impact on human reproduction.
Paavonen J; Eggert-Kruse W
Hum Reprod Update; 1999; 5(5):433-47. PubMed ID: 10582782
[TBL] [Abstract][Full Text] [Related]
3. [Will a vaccine against Chlamydia trachomatis be available soon?].
Baud D; Stojanov M
Rev Med Suisse; 2015 Oct; 11(492):1993-4, 1996-8. PubMed ID: 26672177
[TBL] [Abstract][Full Text] [Related]
4. Chlamydia trachomatis: Protective Adaptive Responses and Prospects for a Vaccine.
Poston TB; Darville T
Curr Top Microbiol Immunol; 2018; 412():217-237. PubMed ID: 27033698
[TBL] [Abstract][Full Text] [Related]
5. Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.
Poston TB; Gottlieb SL; Darville T
Vaccine; 2019 Nov; 37(50):7289-7294. PubMed ID: 28111145
[TBL] [Abstract][Full Text] [Related]
6. Vaccines for Chlamydia infections of the female genital tract.
Hafner LM; McNeilly C
Future Microbiol; 2008 Feb; 3(1):67-77. PubMed ID: 18230035
[TBL] [Abstract][Full Text] [Related]
7. Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.
Rey-Ladino J; Ross AG; Cripps AW
Hum Vaccin Immunother; 2014; 10(9):2664-73. PubMed ID: 25483666
[TBL] [Abstract][Full Text] [Related]
8. Considerations for the rational design of a Chlamydia vaccine.
Liang S; Bulir D; Kaushic C; Mahony J
Hum Vaccin Immunother; 2017 Apr; 13(4):831-835. PubMed ID: 27835064
[TBL] [Abstract][Full Text] [Related]
9. Risk of sequelae after Chlamydia trachomatis genital infection in women.
Haggerty CL; Gottlieb SL; Taylor BD; Low N; Xu F; Ness RB
J Infect Dis; 2010 Jun; 201 Suppl 2():S134-55. PubMed ID: 20470050
[TBL] [Abstract][Full Text] [Related]
10. Towards a Chlamydia trachomatis vaccine: how close are we?
Cochrane M; Armitage CW; O'Meara CP; Beagley KW
Future Microbiol; 2010 Dec; 5(12):1833-56. PubMed ID: 21155665
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of fallopian tube damage caused by Chlamydia trachomatis infections.
Hafner LM
Contraception; 2015 Aug; 92(2):108-15. PubMed ID: 25592078
[TBL] [Abstract][Full Text] [Related]
12. Development status and future prospects for a vaccine against Chlamydia trachomatis infection.
Hafner LM; Wilson DP; Timms P
Vaccine; 2014 Mar; 32(14):1563-71. PubMed ID: 23973245
[TBL] [Abstract][Full Text] [Related]
13. The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women.
Agrawal T; Vats V; Salhan S; Mittal A
J Reprod Immunol; 2009 Dec; 83(1-2):173-8. PubMed ID: 19896206
[TBL] [Abstract][Full Text] [Related]
14. Update on Chlamydia trachomatis Vaccinology.
de la Maza LM; Zhong G; Brunham RC
Clin Vaccine Immunol; 2017 Apr; 24(4):. PubMed ID: 28228394
[TBL] [Abstract][Full Text] [Related]
15. Applying lessons from human papillomavirus vaccines to the development of vaccines against Chlamydia trachomatis.
Frietze KM; Lijek R; Chackerian B
Expert Rev Vaccines; 2018 Nov; 17(11):959-966. PubMed ID: 30300019
[TBL] [Abstract][Full Text] [Related]
16. Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.
Yu H; Karunakaran KP; Jiang X; Brunham RC
Expert Rev Vaccines; 2016 Aug; 15(8):977-88. PubMed ID: 26938202
[TBL] [Abstract][Full Text] [Related]
17. The role of the laboratory in a Chlamydia control programme in a developing country.
Peeling RW; Oyelese AO; Brunham RC; Achola JO; Ronald AR
East Afr Med J; 1992 Sep; 69(9):508-14. PubMed ID: 1286634
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development.
Beagley KW; Timms P
J Reprod Immunol; 2000 Aug; 48(1):47-68. PubMed ID: 10996382
[TBL] [Abstract][Full Text] [Related]
19. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
[TBL] [Abstract][Full Text] [Related]
20. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine.
Brunham RC; Rey-Ladino J
Nat Rev Immunol; 2005 Feb; 5(2):149-61. PubMed ID: 15688042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
